Valuation: UCB

Capitalization 45.58B 53.15B 42.63B 39.81B 74.13B 4,775B 80.3B 500B 193B 2,256B 199B 195B 8,226B P/E ratio 2025 *
41.9x
P/E ratio 2026 * 29.3x
Enterprise value 46.04B 53.69B 43.05B 40.21B 74.87B 4,822B 81.1B 505B 195B 2,279B 201B 197B 8,309B EV / Sales 2025 *
6.33x
EV / Sales 2026 * 5.34x
Free-Float
61.3%
Yield 2025 *
0.59%
Yield 2026 * 0.61%
More valuation ratios * Estimated data
Dynamic Chart
1 day+6.63%
1 week+6.36%
Current month+6.36%
1 month+18.04%
3 months+23.63%
6 months+57.22%
Current year+33.09%
More quotes
1 week 236.8
Extreme 236.8
262
1 month 215.6
Extreme 215.6
262
Current year 129.35
Extreme 129.35
263.2
1 year 129.35
Extreme 129.35
263.2
3 years 65.4
Extreme 65.4
263.2
5 years 65.4
Extreme 65.4
263.2
10 years 54.84
Extreme 54.84
263.2
More quotes
Manager TitleAgeSince
Chief Executive Officer 66 2014-12-31
Director of Finance/CFO 59 2020-06-30
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 54 2011-12-31
Director/Board Member 66 2014-12-31
Director/Board Member 55 2014-04-23
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+6.46%+6.36%+38.08%+257.36% 53.15B
+0.40%-7.88%-4.17%-5.69% 74.16B
-0.81%-1.18%-34.65%-38.63% 59.32B
+1.57%+68.00%+68.00%+68.00% 52.8B
-0.11%+0.02%+13.09%-39.12% 26.7B
-1.66%-2.23%+144.36%+231.53% 20.6B
-1.11%-4.91%+34.63%+20.85% 19.72B
-0.57%-0.38%+63.21%+1,310.33% 18.85B
-0.52%+4.24%+175.87%+689.44% 14.41B
-0.04%-.--%+53.43%+143.84% 14.02B
Average +0.34%-0.91%+55.18%+263.79% 35.37B
Weighted average by Cap. +0.93%-1.34%+33.16%+156.44%
See all sector performances

Financials

2025 *2026 *
Net sales 7.27B 8.48B 6.8B 6.35B 11.82B 761B 12.8B 79.75B 30.77B 360B 31.81B 31.14B 1,312B 8.33B 9.72B 7.79B 7.28B 13.55B 873B 14.68B 91.44B 35.28B 413B 36.48B 35.7B 1,504B
Net income 1.1B 1.28B 1.03B 962M 1.79B 115B 1.94B 12.09B 4.66B 54.53B 4.82B 4.72B 199B 1.54B 1.79B 1.44B 1.34B 2.5B 161B 2.71B 16.85B 6.5B 76.04B 6.72B 6.58B 277B
Net Debt 457M 533M 427M 399M 743M 47.83B 804M 5.01B 1.93B 22.6B 2B 1.96B 82.41B -1.1B -1.28B -1.02B -957M -1.78B -115B -1.93B -12.02B -4.64B -54.21B -4.79B -4.69B -198B
More financial data * Estimated data
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
8,600
More about the company
Date Price Change Volume
25-12-05 249.30 +3.92% 171,175
25-12-04 239.90 +0.04% 141,416
25-12-03 239.80 -1.32% 218,329
25-12-02 243.00 +1.42% 251,804
25-12-01 239.60 -0.37% 201,958

Real-time Euronext Bruxelles, December 05, 2025 at 09:30 am

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
239.90EUR
Average target price
259.61EUR
Spread / Average Target
+8.22%
Consensus

Quarterly revenue - Rate of surprise